Browsing Tag
BofA Securities
13 posts
Ambiq Micro (NYSE: AMBQ) rips 45% on Q1 beat as edge AI demand outruns guidance
AMBQ just printed 75% Q2 growth guidance into a market modelling 36%. The on-device AI silicon thesis is suddenly the only chip trade that does not need a hyperscaler order.
Why Life360 (ASX: 360) is leading ASX 200 gainers ahead of the May 11 Q1 result
Life360 leads the ASX 200, yet shares sit 62% below 2025 highs. The May 11 Q1 print is where the Nativo bet either works or breaks.
Suja Life files for Nasdaq IPO as better-for-you beverage growth meets public market scrutiny
Suja Life has filed for a Nasdaq IPO. Read why its growth, debt load, brand mix, and category timing matter more than the filing itself.
ICICIBANK at Rs 1,310: 38 analysts say buy. April 18 decides.
ICICI Bank (NSE: ICICIBANK) Q4 FY26 results on April 18. PAT consensus ₹11,500 to 12,200 Cr. Analyst targets up to ₹2,040. Key risks, iMobile Pay, and dividend outlook covered.
A $560m test for the diabetes device market as MiniMed prepares to trade on Nasdaq
MiniMed prices its IPO at $20 per share, raising $560M as Medtronic plc spins out its diabetes unit. Discover what the move means for the diabetes technology market.
Sealed Air Corporation (NYSE: SEE) wins stockholder approval for $10.3bn acquisition by CD&R
Sealed Air Corporation wins stockholder approval for its $10.3B CD&R buyout. Discover what this means for packaging markets and investors. Read more.
Lilly to acquire Ventyx Biosciences (Nasdaq: VTYX) in a high-conviction bet on oral inflammation therapies
Eli Lilly is acquiring Ventyx Biosciences for $1.2B to advance oral inflammation therapies. Find out what this means for biotech M&A and chronic care strategy.
Globus Medical to expand into pain management with Nevro acquisition
Globus Medical, Inc., a global leader in musculoskeletal solutions headquartered in Audubon, Pennsylvania, has entered into a definitive…
Keurig Dr Pepper bets $990m on GHOST—Is this the energy drink shake-up we’ve been waiting for?
Keurig Dr Pepper (NASDAQ: KDP) has announced a $990 million agreement to acquire a 60% stake in the…
Ceribell’s stock surges 36% in blockbuster trading debut: AI seizure tech takes Wall Street by storm
In a sensational opening on Wall Street, Ceribell’s stock surged by 36% in its trading debut, reflecting immense…